首页 › 基金 › Cercano Management LLC › DNLI

Cercano Management LLC 对 DNLI 的持仓历史

DENALI THERAPEUTICS INC · 医疗保健

Cercano Management LLC 在 Q3 2026 的 13F 申报中披露持有 DNLI(DENALI THERAPEUTICS INC)625,000 股,市值约 US$12.9M,约占其申报组合的 1.77%,在其申报持仓中市值排名第 7 位。 Cercano Management LLC 最近 13 个申报季度中有 13 个季度披露了 DNLI 持仓,最早可追溯至 Q3 2023。

最新持仓 (Q3 2026)625.00K 股
申报持仓市值$12.92M
组合权重1.77%
首次申报Q3 2023
最近变动持有
更新于2026-11-13

最后更新: 2026-11-13 · 来源: SEC EDGAR Form 13F-HR

Cercano Management LLC 对 DNLI 的持仓演变

Cercano Management LLC 于 Q3 2023 首次披露 DNLI 持仓:625,000 股(约 US$12.9M)。 该持仓在 Q3 2024 达到峰值 625,000 股,市值约 US$18.2M。 在 13 次申报中,Cercano Management LLC 的持股数量始终未变。 最近一期申报(Q3 2026)显示持股 625,000 股、市值约 US$12.9M。

逐季持仓明细

季度股数金额变化
Q3 2023 625.00K $12.89M 新进
Q4 2023 625.00K $13.41M 持有
Q1 2024 625.00K $12.82M 持有
Q2 2024 625.00K $14.51M 持有
Q3 2024 625.00K $18.21M 持有
Q4 2024 625.00K $12.74M 持有
Q1 2025 625.00K $8.50M 持有
Q2 2025 625.00K $8.74M 持有
Q3 2025 625.00K $9.07M 持有
Q4 2025 625.00K $10.32M 持有
Q1 2026 625.00K $12.00M 持有
Q2 2026 625.00K $16.07M 持有
Q3 2026 625.00K $12.92M 持有

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 DNLI 与 13F 数据

DNLI(DENALI THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 40 只申报持有 DNLI,申报仓位最大的包括:淡马锡控股 (US$180.4M), Temasek Holdings (Private) Ltd (US$145.0M), BAKER BROS. ADVISORS LP (US$96.0M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 DNLI 的基金

查看 DNLI 的全部基金持有人 →

常见问题

How long has Cercano Management LLC held DNLI?

Cercano Management LLC has disclosed DNLI holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Cercano Management LLC's current position in DNLI?

As of Q3 2026, Cercano Management LLC holds 625.00K shares of DNLI (DENALI THERAPEUTICS INC), valued at $12.92M, representing 1.77% of its reported portfolio and ranking #7.

Has Cercano Management LLC been buying or selling DNLI?

In the latest 13F filing (Q3 2026), Cercano Management LLC held unchanged its position in DNLI. The position peaked in Q3 2024 at 625.00K shares.

Which other funds hold DNLI?

Other major institutional holders of DNLI include 淡马锡控股, Temasek Holdings (Private) Ltd, BAKER BROS. ADVISORS LP, among 40 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.